Immunotherapy has emerged as a revolutionary approach in the treatment of cancer, largely due to its ability to harness the body's immune system to fight tumors. Central to this progress is the use of the syngeneic mice model, which provides a biologically relevant system to study immune responses to tumors. Unlike models that use immunodeficient h